ASCO 2019: T-VEC shows improved survival over cytokine therapy in patients with melanoma
Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma…
Browsing: immunotherapy T-VEC
Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma…